5 Hydroxytryptamine Receptor 1F (5 Ht1F) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
The 5-HT1F receptor is a serotonin receptor subtype belonging to the G protein-coupled receptor (GPCR) superfamily. It is negatively coupled to adenylyl cyclase via Gi/o proteins, resulting in decreased cAMP production. The 5-HT1F receptor is expressed in the trigeminal ganglion, [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), and dorsal raphe nucleus, where it modulates neurotransmitter release and participates in migraine pathophysiology. [@berger2009]
5 Hydroxytryptamine Receptor 1F (5 Ht1F) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
The 5-HT1F receptor is a serotonin receptor subtype belonging to the G protein-coupled receptor (GPCR) superfamily. It is negatively coupled to adenylyl cyclase via Gi/o proteins, resulting in decreased cAMP production. The 5-HT1F receptor is expressed in the trigeminal ganglion, [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), and dorsal raphe nucleus, where it modulates neurotransmitter release and participates in migraine pathophysiology. [@berger2009]
Structure
5-HT1F is a typical GPCR with: [@hargreaves2022]
Seven transmembrane α-helical domains
Extracellular N-terminus for ligand binding
Intracellular C-terminus for G protein coupling
Gi/o protein coupling specificity
Key structural features: [@lucas1997]
Highly conserved binding pocket for tryptamine derivatives
Distinct from other 5-HT1 subtypes
No crystal structure available, homology models used
Function
Migraine Modulation
5-HT1F receptors are key in migraine: [^5]
Located on trigeminal nociceptors
Mediates serotonin-induced cranial vasodilation
Pain signal modulation
Target for acute migraine treatment
Neurotransmitter Regulation
In the CNS, 5-HT1F modulates: [^6]
Glutamate release in cortex
Dopamine release in striatum
GABA release in hippocampus
Serotonin autoreceptor function
Cognitive Function
In hippocampus and cortex:
Modulates learning and memory
Affects synaptic plasticity
Potential cognitive effects
Role in Neurodegenerative Diseases
Alzheimer's Disease
5-HT1F expression altered in AD cortex
May affect cholinergic modulation
Therapeutic potential being explored
Parkinson's Disease
Serotonergic dysfunction in PD
5-HT1F modulation of dopamine release
Potential for non-motor symptoms
Migraine
Direct target for migraine abortives
Lasmiditan (selective 5-HT1F agonist)
No vasoconstriction risk
Therapeutic Targeting
5-HT1F agonists are used for:
Acute migraine treatment (lasmiditan)
Potential neuropathic pain
Investigational for PD motor complications
Research Directions
Development of more selective 5-HT1F agonists
Understanding isoform-specific functions
Combination therapies
Biomarker development
Background
The study of 5 Hydroxytryptamine Receptor 1F (5 Ht1F) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
The 5-HT1F receptor is expressed throughout the central nervous system with particularly high levels in:
Cortex (frontal, parietal)
Hippocampus
Thalamus
Trigeminal nucleus
Spinal cord dorsal horn
Therapeutic Targeting
The 5-HT1F receptor has emerged as a promising drug target:
Migraine: Frovatriptan and lasmiditan are 5-HT1F agonists used for acute migraine treatment. Unlike triptans, they lack significant vasoconstrictive effects.
Neuroprotection: 5-HT1F activation may provide neuroprotective effects through:
Inhibition of glutamate release
Reduction of cAMP
Modulation of calcium channels
Anti-inflammatory effects
Potential for Neurodegeneration:
May protect against excitotoxicity
Could reduce neuroinflammation
Possible benefits in AD, PD, HD
Signaling Mechanisms
5-HT1F is a Gi/o-coupled receptor that:
Inhibits adenylate cyclase
Opens potassium channels
Closes calcium channels
Reduces neuronal firing
Therapeutic Implications
Drug Development
Selective 5-HT1F agonists offer advantages:
No coronary vasoconstriction
Safe for cardiovascular patients
Effective for migraine with aura
Clinical Considerations
Generally well-tolerated
May cause dizziness, nausea
Contraindications similar to other serotonergic drugs
References
[@lucas1997]: Lucas RJ. 5[^5]: Peroutka SJ. 5-HT receptor subtypes. Annu Rev Neurosci. 1997;20:17[^6]: Ramadan NM. Lasmiditan: a review. Headache. 2019;59(2):302-315.
Brain Atlas Resources
[Allen Human Brain Atlas search: 5-HT1F](https://human.brain-map.org/search?searchText=5-HT1F)